BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19768921)

  • 1. [Progress in antiarrhythmic therapy].
    Yamashita T
    Nihon Rinsho; 2009 Sep; 67(9):1811-20. PubMed ID: 19768921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-drug therapy of ventricular tachycardia/ventricular fibrillation].
    Steinbach K; Frohner K; Hief C; Kaltenbrunner W; Nürnberg M; Podczeck A; Veit F
    Wien Med Wochenschr; 1992; 142(15-16):367-70. PubMed ID: 1481542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical cardiac electrophysiology in West Virginia: 2010.
    Faulknier BA; Trotter CC; Navarengom KB
    W V Med J; 2011; 107(2):30-6. PubMed ID: 21476475
    [No Abstract]   [Full Text] [Related]  

  • 4. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 6. Current management of ventricular arrhythmias.
    Anderson MH
    Br J Hosp Med; 1994 Sep 7-20; 52(5):204-9. PubMed ID: 7529627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Almanac 2011: Cardiac arrhythmias and pacing. Review of selected studies that have driven recent advances in clinical cardiology -- by the Editors of the Network Task Force of the European Society of Cardiology].
    Liew R
    G Ital Cardiol (Rome); 2012 May; 13(5):314-25. PubMed ID: 22539136
    [No Abstract]   [Full Text] [Related]  

  • 9. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ventricular fibrillation/tachycardia].
    Aizawa Y
    Nihon Rinsho; 2002 Jul; 60(7):1382-8. PubMed ID: 12136618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB; Roy D
    Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials of implantable defibrillators.
    Myerburg RJ; Castellanos A
    N Engl J Med; 1997 Nov; 337(22):1621-3. PubMed ID: 9371860
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ventricular tachycardia and ventricular fibrillation. Diagnostic procedure for selection of patients for non-medicamentous therapeutic procedures].
    Schmidinger H
    Wien Med Wochenschr; 1992; 142(15-16):341-6. PubMed ID: 1481538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias.
    Krol RB; Saksena S; Prakash A
    Curr Cardiol Rep; 1999 Nov; 1(4):282-8. PubMed ID: 10980855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
    Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with the implantable cardioverter defibrillator (ICD)].
    Jordaens LJ
    Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.